The effect of Neurobion in the treatment of Thalassemia
Early Phase 1
- Conditions
- Major Thalassemia.
- Registration Number
- IRCT20180602039941N1
- Lead Sponsor
- Arak University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
All patients with Thalassemia major over 10 years of age
Exclusion Criteria
Patients who do not wish to participate in this plan
Patients with Hepatitis and Renal failure
Patients with Thalassemia major under 10 years of age
Patients with alloimmunization
Patients who do not receive Zinc sulfate, Calcium and Folic acid
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method